Apertura Gene Therapy
PrivateLast Round
Series A
Apr 26, 2022
Total Funding Raised
$67M
Company Overview
Apertura Gene Therapy is a biotechnology company that develops genetic medicines and next-generation AAV capsids designed to enable effective and selective gene delivery across the blood-brain barrier.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apertura Gene Therapy Comparables
Compare Apertura Gene Therapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dyno Therapeutics | 84% | |
| Capsida Biotherapeutics | 84% | |
| Shape Therapeutics | 83% | |
Apertura Gene Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 26, 2022 |
Key People
Founding team and executive leadership
Apertura Gene Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2026
Open Aperture provides researchers access to TfR1 CapX technology.
- Jan 1, 2026
Collaborating with Viralgen Vector Core to advance novel therapies.
Apertura Gene Therapy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apertura Gene Therapy's valuation, stock price, and market status.